0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Acinetobacter Infections Treatment Market Report & Forecast 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Auto-L9
Home | Market Reports | Health | Health Conditions | Infectious Diseases
China Acinetobacter Infections Treatment Market Report Forecast 2021 2027

China Acinetobacter Infections Treatment Market Report & Forecast 2021-2027

Code: QYRE-Auto-L9
Report
August 2021
90 Pages
QYResearch
Region: Global, United States, China,
Description
Table of Content
Tables & Figures
China Acinetobacter Infections Treatment Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Acinetobacter Infections Treatment Market Segment Percentages, By Type, 2020 (%)
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
China Acinetobacter Infections Treatment Market, By Pipeline, 2016-2021, 2022-2027 ($ Millions)
China Acinetobacter Infections Treatment Market Segment Percentages, By Pipeline, 2020 (%)
ETX2514
Nacubactam RG6080
Arenicin
VXD-001
Small Molecule Antibiotic
AR-401 mAB
LCB01-0371 (PO)
GN-4474
Antibacterial Antibody
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acinetobacter Infections Treatment revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Acinetobacter Infections Treatment revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
1 Introduction to Research & Analysis Reports
1.1 Acinetobacter Infections Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Pipeline
1.3 China Acinetobacter Infections Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Acinetobacter Infections Treatment Overall Market Size
2.1 China Acinetobacter Infections Treatment Market Size: 2021 VS 2027
2.2 China Acinetobacter Infections Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acinetobacter Infections Treatment Players in China Market
3.2 Top China Acinetobacter Infections Treatment Companies Ranked by Revenue
3.3 China Acinetobacter Infections Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acinetobacter Infections Treatment Companies in China Market, by Revenue in 2020
3.5 Companies Acinetobacter Infections Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acinetobacter Infections Treatment Players in China Market
3.6.1 List of Tier 1 Acinetobacter Infections Treatment Companies in China
3.6.2 List of Tier 2 and Tier 3 Acinetobacter Infections Treatment Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Acinetobacter Infections Treatment Market Size Markets, 2021 & 2027
4.1.2 Sulbactam
4.1.3 Carbapenems
4.1.4 Aminoglycosides
4.1.5 Polymyxins
4.1.6 Tetracyclines
4.1.7 Others
4.2 By Type - China Acinetobacter Infections Treatment Revenue & Forecasts
4.2.1 By Type - China Acinetobacter Infections Treatment Revenue, 2016-2021
4.2.2 By Type - China Acinetobacter Infections Treatment Revenue, 2022-2027
4.2.3 By Type - China Acinetobacter Infections Treatment Revenue Market Share, 2016-2027
5 Sights by Pipeline
5.1 Overview
5.1.1 By Pipeline - China Acinetobacter Infections Treatment Market Size, 2021 & 2027
5.1.2 ETX2514
5.1.3 Nacubactam RG6080
5.1.4 Arenicin
5.1.5 VXD-001
5.1.6 Small Molecule Antibiotic
5.1.7 AR-401 mAB
5.1.8 LCB01-0371 (PO)
5.1.9 GN-4474
5.1.10 Antibacterial Antibody
5.1.11 Others
5.2 By Pipeline - China Acinetobacter Infections Treatment Revenue & Forecasts
5.2.1 By Pipeline - China Acinetobacter Infections Treatment Revenue, 2016-2021
5.2.2 By Pipeline - China Acinetobacter Infections Treatment Revenue, 2022-2027
5.2.3 By Pipeline - China Acinetobacter Infections Treatment Revenue Market Share, 2016-2027
6 Acinetobacter Infections Treatment Companies Profiles
6.1 Entasis Therapeutics
6.1.1 Entasis Therapeutics Company Details
6.1.2 Entasis Therapeutics Business Overview
6.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Introduction
6.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.1.5 Entasis Therapeutics Recent Developments
6.2 Roche
6.2.1 Roche Company Details
6.2.2 Roche Business Overview
6.2.3 Roche Acinetobacter Infections Treatment Introduction
6.2.4 Roche Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.2.5 Roche Recent Developments
6.3 Adenium Biotech
6.3.1 Adenium Biotech Company Details
6.3.2 Adenium Biotech Business Overview
6.3.3 Adenium Biotech Acinetobacter Infections Treatment Introduction
6.3.4 Adenium Biotech Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.3.5 Adenium Biotech Recent Developments
6.4 Vaxdyn
6.4.1 Vaxdyn Company Details
6.4.2 Vaxdyn Business Overview
6.4.3 Vaxdyn Acinetobacter Infections Treatment Introduction
6.4.4 Vaxdyn Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.4.5 Vaxdyn Recent Developments
6.5 Hsiri Therapeutics
6.5.1 Hsiri Therapeutics Company Details
6.5.2 Hsiri Therapeutics Business Overview
6.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Introduction
6.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.5.5 Hsiri Therapeutics Recent Developments
6.6 Aridis Pharmaceuticals
6.6.1 Aridis Pharmaceuticals Company Details
6.6.2 Aridis Pharmaceuticals Business Overview
6.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Introduction
6.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.6.5 Aridis Pharmaceuticals Recent Developments
6.7 LegoChem Biosciences
6.7.1 LegoChem Biosciences Company Details
6.7.2 LegoChem Biosciences Business Overview
6.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Introduction
6.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.7.5 LegoChem Biosciences Recent Developments
6.8 Atterx Biotherapeutics
6.8.1 Atterx Biotherapeutics Company Details
6.8.2 Atterx Biotherapeutics Business Overview
6.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Introduction
6.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.8.5 Atterx Biotherapeutics Recent Developments
6.9 Achaogen
6.9.1 Achaogen Company Details
6.9.2 Achaogen Business Overview
6.9.3 Achaogen Acinetobacter Infections Treatment Introduction
6.9.4 Achaogen Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.9.5 Achaogen Recent Developments
6.10 Peptilogics
6.10.1 Peptilogics Company Details
6.10.2 Peptilogics Business Overview
6.10.3 Peptilogics Acinetobacter Infections Treatment Introduction
6.10.4 Peptilogics Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.10.5 Peptilogics Recent Developments
6.11 Sealife PHARMA
6.11.1 Sealife PHARMA Company Details
6.11.2 Sealife PHARMA Business Overview
6.11.3 Sealife PHARMA Acinetobacter Infections Treatment Introduction
6.11.4 Sealife PHARMA Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.11.5 Sealife PHARMA Recent Developments
6.12 Shionogi
6.12.1 Shionogi Company Details
6.12.2 Shionogi Business Overview
6.12.3 Shionogi Acinetobacter Infections Treatment Introduction
6.12.4 Shionogi Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.12.5 Shionogi Recent Developments
6.13 Techulon
6.13.1 Techulon Company Details
6.13.2 Techulon Business Overview
6.13.3 Techulon Acinetobacter Infections Treatment Introduction
6.13.4 Techulon Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.13.5 Techulon Recent Developments
6.14 Tetraphase Pharmaceuticals
6.14.1 Tetraphase Pharmaceuticals Company Details
6.14.2 Tetraphase Pharmaceuticals Business Overview
6.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Introduction
6.14.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue in China Market (2016-2021)
6.14.5 Tetraphase Pharmaceuticals Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
    Table 1. Acinetobacter Infections Treatment Market Opportunities & Trends in China Market
    Table 2. Acinetobacter Infections Treatment Market Drivers in China Market
    Table 3. Acinetobacter Infections Treatment Market Restraints in China Market
    Table 4. Key Players of Acinetobacter Infections Treatment in China Market
    Table 5. Top Acinetobacter Infections Treatment Players in China Market, Ranking by Revenue (2019)
    Table 6. China Acinetobacter Infections Treatment Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. China Acinetobacter Infections Treatment Revenue Share by Companies, 2016-2021
    Table 8. Companies Acinetobacter Infections Treatment Product Type
    Table 9. List of Tier 1 Acinetobacter Infections Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Acinetobacter Infections Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – China Acinetobacter Infections Treatment Revenue, (US$, Mn), 2021 & 2027
    Table 12. By Type - China Acinetobacter Infections Treatment Revenue (US$, Mn), 2016-2021
    Table 13. By Type - China Acinetobacter Infections Treatment Revenue (US$, Mn), 2022-2027
    Table 14. By Pipeline – China Acinetobacter Infections Treatment Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Pipeline - China Acinetobacter Infections Treatment Revenue (US$, Mn), 2016-2021
    Table 16. By Pipeline - China Acinetobacter Infections Treatment Revenue (US$, Mn), 2022-2027
    Table 17. Entasis Therapeutics Company Details
    Table 18. Entasis Therapeutics Business Overview
    Table 19. Entasis Therapeutics Acinetobacter Infections Treatment Product
    Table 20. Entasis Therapeutics Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 21. Entasis Therapeutics Recent Developments
    Table 22. Roche Company Details
    Table 23. Roche Business Overview
    Table 24. Roche Acinetobacter Infections Treatment Product
    Table 25. Roche Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 26. Roche Recent Developments
    Table 27. Adenium Biotech Company Details
    Table 28. Adenium Biotech Business Overview
    Table 29. Adenium Biotech Acinetobacter Infections Treatment Product
    Table 30. Adenium Biotech Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 31. Adenium Biotech Recent Developments
    Table 32. Vaxdyn Company Details
    Table 33. Vaxdyn Business Overview
    Table 34. Vaxdyn Acinetobacter Infections Treatment Product
    Table 35. Vaxdyn Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 36. Vaxdyn Recent Developments
    Table 37. Hsiri Therapeutics Company Details
    Table 38. Hsiri Therapeutics Business Overview
    Table 39. Hsiri Therapeutics Acinetobacter Infections Treatment Product
    Table 40. Hsiri Therapeutics Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 41. Hsiri Therapeutics Recent Developments
    Table 42. Aridis Pharmaceuticals Company Details
    Table 43. Aridis Pharmaceuticals Business Overview
    Table 44. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product
    Table 45. Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 46. Aridis Pharmaceuticals Recent Developments
    Table 47. LegoChem Biosciences Company Details
    Table 48. LegoChem Biosciences Business Overview
    Table 49. LegoChem Biosciences Acinetobacter Infections Treatment Product
    Table 50. LegoChem Biosciences Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 51. LegoChem Biosciences Recent Developments
    Table 52. Atterx Biotherapeutics Company Details
    Table 53. Atterx Biotherapeutics Business Overview
    Table 54. Atterx Biotherapeutics Acinetobacter Infections Treatment Product
    Table 55. Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 56. Atterx Biotherapeutics Recent Developments
    Table 57. Achaogen Company Details
    Table 58. Achaogen Business Overview
    Table 59. Achaogen Acinetobacter Infections Treatment Product
    Table 60. Achaogen Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 61. Achaogen Recent Developments
    Table 62. Peptilogics Company Details
    Table 63. Peptilogics Business Overview
    Table 64. Peptilogics Acinetobacter Infections Treatment Product
    Table 65. Peptilogics Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 66. Peptilogics Recent Developments
    Table 67. Sealife PHARMA Company Details
    Table 68. Sealife PHARMA Business Overview
    Table 69. Sealife PHARMA Acinetobacter Infections Treatment Product
    Table 70. Sealife PHARMA Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 71. Sealife PHARMA Recent Developments
    Table 72. Shionogi Company Details
    Table 73. Shionogi Business Overview
    Table 74. Shionogi Acinetobacter Infections Treatment Product
    Table 75. Shionogi Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 76. Shionogi Recent Developments
    Table 77. Techulon Company Details
    Table 78. Techulon Business Overview
    Table 79. Techulon Acinetobacter Infections Treatment Product
    Table 80. Techulon Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 81. Techulon Recent Developments
    Table 82. Tetraphase Pharmaceuticals Company Details
    Table 83. Tetraphase Pharmaceuticals Business Overview
    Table 84. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product
    Table 85. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue in China Market (2016-2021) & (US$ Million)
    Table 86. Tetraphase Pharmaceuticals Recent Developments
List of Figures
    Figure 1. Acinetobacter Infections Treatment Segment by Type
    Figure 2. Acinetobacter Infections Treatment Segment by Pipeline
    Figure 3. China Acinetobacter Infections Treatment Market Overview: 2020
    Figure 4. China Acinetobacter Infections Treatment Market Size: 2021 VS 2027 (US$, Mn)
    Figure 5. China Acinetobacter Infections Treatment Revenue, 2016-2027 (US$, Mn)
    Figure 6. The Top 3 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2020
    Figure 7. By Type - China Acinetobacter Infections Treatment Revenue Market Share, 2016-2027
    Figure 8. By Pipeline - China Acinetobacter Infections Treatment Revenue Market Share, 2016-2027
    Figure 9. Entasis Therapeutics Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 10. Roche Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 11. Adenium Biotech Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 12. Vaxdyn Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 13. Hsiri Therapeutics Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 14. Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 15. LegoChem Biosciences Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 16. Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 17. Achaogen Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 18. Peptilogics Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 19. Sealife PHARMA Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 20. Shionogi Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 21. Techulon Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 22. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global Meningococcal Conjugate Market Insights Forecast to 2028
Global Meningococcal Conjugate Market Insights, Forecast to 2028

Two meningitis vaccines protects against four types of meningococcal disease.Market Analysis and Insights Global Meningococcal Conjugate MarketThe global Meningococcal Conjugate market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Menactra accounting for of the Meningococcal Conjugate global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-33R5929
Wed Jan 26 00:00:00 UTC 2022

Add to Cart

Global Tamiflu Oseltamivir Phosphate Market Insights and Forecast to 2028
Global Tamiflu (Oseltamivir Phosphate) Market Insights and Forecast to 2028

Oseltamivir sold under the brand nameTamiflu is anantiviral medicationused to treat and preventinfluenza Aandinfluenza Bflu.Market Analysis and Insights Global Tamiflu Oseltamivir Phosphate MarketDue to the COVID19 pandemic the global Tamiflu Oseltamivir Phosphate market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-14K724
Wed Jan 26 00:00:00 UTC 2022

Add to Cart

Global Acquired Infections Testing Market Insights Forecast to 2028
Global Acquired Infections Testing Market Insights, Forecast to 2028

Market Analysis and Insights Global Acquired Infections Testing MarketThe global Acquired Infections Testing market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Disease Testing accounting for of the Acquired Infections Testing global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-11W6083
Wed Jan 26 00:00:00 UTC 2022

Add to Cart

Global Enterovirus and Parechovirus Testing Market Insights and Forecast to 2028
Global Enterovirus and Parechovirus Testing Market Insights and Forecast to 2028

Human parechoviruses may cause gastrointestinal or respiratory illness in infants and have been implicated in cases of myocarditis and encephalitis.Market Analysis and Insights Global Enterovirus and Parechovirus Testing MarketThe global Enterovirus and Parechovirus Testing market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis RTPCR accounting for of the Enterovirus and Parechovirus Testing global market in 2021 is projected .

120 Pages
Type: Report
Code: QYRE-Auto-32G8368
Mon Jan 24 00:00:00 UTC 2022

Add to Cart